Advertisement
Advertisement

FULC

FULC logo

Fulcrum Therapeutics, Inc. Common Stock

7.01
USD
Sponsored
+0.13
+1.89%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

7.00

0.00
-0.07%

Fulcrum Therapeutics, Inc. Common Stock Profile

About

Fulcrum Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on genetically defined diseases with an initial focus on rare diseases. Fulcrum Therapeutics Inc. is based in Cambridge, United States.

Info & Links

CEO

Alex C. Sapir

Headquarters

26 LANDSDOWNE STREET
CAMBRIDGE, MA 02139, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.fulcrumtx.com

Auditor

Ernst & Young LLP

Share holders

11

Employees

55

Fulcrum Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

466.77M

Enterprise Value

269.23M

Enterprise Value/EBITDA(ttm)

-3.23

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.23

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-30.25%

Return on Invested Capital(ttm)

-31.50%

Return on Assets(ttm)

-28.45%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-83.38M

Net Income Available to Common(ttm)

-74.88M

Diluted EPS(ttm)

-1.18

Share Statistics

Beta (5Y Monthly)

3.27

52-Week Change

29.57%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

66.60M

Dividend Yield

0.00%

Float4

61.94M

% Held by Insiders

7.00%

% Held by Institutions

89.83%

Balance Sheet

Total Cash(mrq)

352.31M

Total Cash Per Share(mrq)

5.29

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

27.40%

Quick Ratio(mrq)

27.40%

Book Value Per Share(mrq)

5.24

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.95

Free Cash Flow(ytd)

-60.38M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement